X-node supplies extraction instruments and reagents from global leaders such as Promega, Qiagen, AmoyDx and Thermo Fisher Scientific.

In vitro diagnostic medical devices for cancer refer to medical tools used to analyze samples collected from the human body—such as blood, tissue, urine, or saliva—outside the body to determine the presence of cancer, identify genetic mutations, monitor treatment responses, and assess prognosis.

Z-node is a central pillar in Epinode’s mission to conquer cancer through diagnostics. While X-node focuses on the extraction of biological signals (such as DNA, cfDNA, and CTCs), and Y-node delivers precise cancer detection and classification, Z-node serves as the intelligent platform that integrates, interprets, and activates diagnostic data to drive strategic cancer control. Z-node is not merely a data interpretation tool—it is a strategic platform that enables: Prediction of cancer risk before clinical symptoms appear Integration of epigenetic and lifestyle data to uncover modifiable, early-stage changes Design of personalized treatment strategies through companion diagnostics and therapy matching Forecasting of recurrence and metastasis, and reinforcement of longitudinal monitoring Clinical decision support for both physicians and patients to take timely, informed actions At its core, Z-node transforms diagnostics into a proactive weapon against cancer. Through AI-driven analysis and multi-omics integration, Z-node empowers healthcare professionals to detect earlier, treat smarter, and track continuously—delivering on the full promise of precision oncology.